+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Macular Edema"

From
From
Macular Edema - Global Clinical Trials Review, 2024 - Product Thumbnail Image

Macular Edema - Global Clinical Trials Review, 2024

  • Clinical Trials
  • November 2024
  • 893 Pages
  • Global
From
From
From
From
From
From
Diabetic Retinopathy Treatment - Global Strategic Business Report - Product Thumbnail Image

Diabetic Retinopathy Treatment - Global Strategic Business Report

  • Report
  • February 2025
  • 273 Pages
  • Global
From
Retinal Biologics Market Report 2025 - Product Thumbnail Image

Retinal Biologics Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Retinal Laser Equipment - Global Strategic Business Report - Product Thumbnail Image

Retinal Laser Equipment - Global Strategic Business Report

  • Report
  • March 2025
  • 92 Pages
  • Global
From
From
Loading Indicator

Macular Edema is a condition in which fluid accumulates in the macula, the central part of the retina responsible for sharp, central vision. It is a common complication of diabetes, and can also be caused by other diseases or conditions such as uveitis, retinal vein occlusion, and retinopathy of prematurity. Treatment options for macular edema include laser photocoagulation, intravitreal injections, and vitrectomy. Optical treatments for macular edema include laser photocoagulation, which uses a laser to reduce the amount of fluid in the macula. Intravitreal injections are also used to reduce fluid accumulation, and vitrectomy is a surgical procedure that removes the vitreous gel from the eye and replaces it with a gas bubble. Companies in the macular edema market include Regeneron Pharmaceuticals, Allergan, Novartis, Roche, and Bayer. Show Less Read more